Back to top

Recordati extends rare disease-led growth, lifts profitability in H1 2026

An announcement from Recordati Industria Chimica e Farmaceutica SPA ( ($IT:REC) ) is now available. Recordati reported consolidated net revenues of...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Recordati Industria Chimica E Farmaceutica S.P.A. (RCDTF)